Smart Nanotechnology to Enhancing Drug Delivery and Bioavailability
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 30 April 2024 | Viewed by 197
Special Issue Editor
Interests: nanotechnology in drug delivery; bioavailability enhancement; nanostructured drug formulations; pharmacokinetics of nanoparticles; nanomedicine
Special Issue Information
Dear Colleagues,
In the dynamic landscape of pharmaceuticals, enhancing drug bioavailability remains a pivotal challenge, often addressed through innovative nanotechnology applications. This Special Issue delves into the cutting-edge strategies utilizing diverse nanostructures to revolutionize drug delivery systems. We are particularly interested in submissions that demonstrate how these nanostructures facilitate targeted delivery, improve pharmacokinetic profiles and overcome biological barriers, thereby enhancing the therapeutic effectiveness and safety profiles of drugs. The issue aims to highlight advancements in nanocarrier design that optimize the release and absorption of active pharmaceutical ingredients, addressing the critical aspects of solubility, stability and controlled release in drug delivery.
We encourage contributions that showcase novel methodologies and practical aspects of smart nanotechnology in enhancing drug delivery systems and improving bioavailability. Submissions may include, but are not limited to, studies on formulation strategies, in vivo and in vitro evaluations, and the impact of nanotechnology on the pharmacodynamics and pharmacokinetics of drugs. We welcome research that bridges the gap between nanotechnology and practical pharmaceutical applications, offering insights into the future of drug delivery and bioavailability enhancement. We look forward to receiving your contributions.
Dr. Rubiana Mara Mainardes
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanotechnology
- drug bioavailability
- nanostructures
- targeted drug delivery
- pharmacokinetics
- pharmacodynamics
